Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 7 of the 15 sources its claims cite were checked for support.
Abstract
Introduction Hypoxic-ischemic encephalopathy (HIE) remains a leading cause of neonatal neurological injury, and therapeutic hypothermia is the established treatment shown to reduce brain injury in neonates with moderate to severe HIE. The systemic laboratory response to hypoxic-ischemic injury and its relationship to brain injury severity are not fully understood. Methods This retrospective cohort included 152 neonates born at a gestational age of 35 weeks or greater who met criteria for therapeutic hypothermia for HIE at UF Health Shands Children's Hospital between 2012 and 2024. Laboratory data were collected at seven time intervals from birth through rewarming and analyzed using linear mixed-effects models to characterize temporal trends. Temporal analyses revealed changes across metabolic, hepatic, and coagulation biomarkers during and after therapeutic hypothermia, with several values demonstrating significant variation at specific time points. Neonates were classified by sentinel event status (definite, probable, or none), and temporal trends demonstrated differences between the groups. The laboratory values were correlated with magnetic resonance imaging (MRI) injury severity using the Weeke scoring system. Results Early metabolic derangements, including lower pH and more negative base deficit values, were significantly associated with higher MRI injury scores across all regions, including gray matter, white matter, and the cerebellum. Machine-learning models that integrate a combination of early laboratory timepoints improve the prediction of MRI-defined injury, with the best performance achieved using pH at T1, pCO₂ at T1, and lactate at T3 (adjusted R ² = 0.47). Conclusion These findings demonstrate temporal laboratory trajectories during and after therapeutic hypothermia, supporting the prognostic utility of serial biomarkers and machine-learning-based modeling in neonatal HIE.
Overview
CoChat Summary
TL;DR
In this single-center retrospective cohort of 152 neonates with HIE treated with therapeutic hypothermia, serial labs showed distinct trajectories over cooling/rewarming, and early abnormalities in acid-base, lactate, transaminases, and coagulation markers were associated with MRI-defined brain injury. A multivariable model using early pH, pCO2, and lactate explained up to 46.8% of the variance in total MRI injury score on the observed dataset.
Key findings
- The cohort included 152 neonates; 55% male, mean gestational age 38 ± 2 weeks, and mean birth weight 3,214 ± 727 g.
- Across the full cohort, ALT peaked at T2 (median 50 U/L vs 25 U/L at T1) and AST peaked at T2 (median 130 U/L vs 75 U/L at T1), both with p < 0.05; lactate was highest at T1 (median 9 mmol/L) and declined to a median of 1 mmol/L by T7.
- Early metabolic abnormalities were linked to worse MRI injury: lower pH, more negative base deficit, and higher lactate were associated with higher injury scores across gray matter, white matter, cerebellum, and total brain injury scores.
- The best multivariable predictive model for total MRI brain injury used pH at T1, pCO2 at T1, and lactate at T3, with adjusted R² = 46.8% on the observed dataset and 34.1% on the imputed dataset; a simpler two-predictor model (pCO2 at T1 + lactate at T3) reached adjusted R² = 42.7% observed and 29.6% imputed.
Methods
- Design/sample: Single-center retrospective cohort at UF Health Shands Children’s Hospital (2012–2024), including 152 neonates ≥35 weeks’ gestation who met criteria for therapeutic hypothermia for HIE.
- Data collection: Laboratory values were extracted from the EHR at seven time intervals: T1 0–6 h, T2 6–12 h, T3 12–24 h, T4 24–48 h, T5 48–72 h, T6 72–96 h, and T7 >96 h.
- Main analysis: Temporal trends were tested with linear mixed-effects models; MRI injury was scored with the Weeke system by a blinded neuroradiologist; prediction used linear regression/model selection, including BIC, five-fold block cross-validation, and multiple imputation for missing predictors.
Limitations
- The paper explicitly states that the single-center design may limit generalizability.
- The paper explicitly notes non-uniform laboratory timing, missing values, MRI timing variability, and possible retrospective misclassification of sentinel events, especially among outborn infants.
- Evident from the text: the analysis is retrospective, so it cannot establish causality; also, some reported associations may reflect therapy-related effects rather than primary injury, as the authors note.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
6 Valid · 0 Not valid · 0 Not checked · 104 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Emerging evidence highlights that factors such as hypocapnia, hyperoxia, extreme fluctuations in blood pressure and glucose are associated with worse outcomes in this population (1, 4–8).”
§ Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia > Introduction
What the sources say
- Not checked — no full text of the sourcecites [1] Douglas-Escobar, 2015, Hypoxic-ischemic encephalopathy: a review for the clinician, JAMA Pediatr source
- Not checked — no full text of the sourcecites [4] Lingappan, 2016, Relationship between PCO2 and unfavorable outcome in infants with moderate-to-severe hypoxic ischemic encephalopathy, Pediatr Res source
- Partly supportedcites [5] Badurdeen, 2024, Early hyperoxemia and 2-year outcomes in infants with hypoxic-ischemic encephalopathy: a secondary analysis of the infant cooling evaluation;trial, J Pediatr sourceExperimental — accuracy not yet measured
The Results report that early hyperoxemia was associated with a higher risk of death or major disability in infants with HIE. The Discussion also reports an earlier study linking severe hypocarbia to death or disability. Our copy does not support the sentence’s additional claim about extreme fluctuations in blood pressure or glucose. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [6] Salhab, 2004, Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia, Pediatrics source
- Supportedcites [7] Parmentier, 2022, Hypoglycemia in infants with hypoxic-ischemic encephalopathy is associated with additional brain injury and worse neurodevelopmental outcome, J Pediatr source
The Discussion reports that hypoglycemia in infants with HIE was associated with more severe brain injury and worse preschool outcomes. It also reports that infants who experienced both hypoglycemia and hyperglycemia had worse cognitive scores at age 2. This supports the glucose component of the multiply cited sentence; the paper need not establish its claims about hypocapnia, hyperoxia, or blood pressure. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [8] Giesinger, 2017, Hypoxic-Ischemic encephalopathy and therapeutic hypothermia: the hemodynamic perspective, J Pediatr source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Overall, most pCO2 measurements remained within the normal range (35–45 mmHg) (13–15).”
§ Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia > Results > CO2 Laboratory trends over time
What the sources say
- Not checked — no full text of the sourcecites [13] Tan, 2008, Acid–base physiology and blood gas interpretation in the neonate, Paediatr Child Health (Oxford) source
- Not checked — no full text of the sourcecites [14] Cowley, 2013, Interpreting arterial blood gas results, Br Med J source
- Partly supportedcites [15] Larkin, 2015, Interpreting arterial blood gases successfully, Aorn J sourceExperimental — accuracy not yet measured
The “PaO₂ and PaCO₂” section identifies values below 35 mm Hg as low and above 45 mm Hg as high, supporting the stated normal range. It does not report a set of pCO₂ measurements or establish that most remained within that range; the scenarios give individual examples instead. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Our findings demonstrated that pCO2, lactate, ALT, AST, pH, PT-INR, PTT and D-dimer, were significantly associated with brain injury patterns as assessed using the Weeke scoring system (9).”
§ Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia > Discussion This single-center retrospective cohort study examined temporal trends in laboratory biomarkers among neonates with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH). Laboratory values were collected at seven predefined time points from birth through beyond 96 h of life, encompassing the entire course of cooling and rewarming. This longitudinal approach enabled a comprehensive evaluation of how bedside laboratory values, including liver enzymes, acid-base status, renal function, cardiac injury indicators, and coagulation parameters, changed over time, providing clinicians with an expected temporal profile of laboratory trends following HIE. Most abnormalities were observed within the first 24 h of life, with gradual normalization thereafter. These data provide an expected clinical trajectory for laboratory values in neonates with HIE undergoing therapeutic hypothermia. Subsequently, the relationship between routine bedside laboratory values and MRI-defined brain injury was investigated to assess whether these laboratory results could serve as surrogate indicators of neurologic injury. MRI brain injury scores, assessed using the Weeke classification, were analyzed for associations with laboratory markers reflective of multisystem injury and physiologic disturbances, and their correlation with the severity of brain injury. Among evaluated laboratory markers, lactate, pH, pCO2, and base deficit demonstrated the most consistent early associations with MRI-defined brain injury, while transaminases and coagulation parameters showed additional time-dependent relationships. Similar temporal trajectories in laboratory biomarkers have been reported in prior studies of neonates with HIE; however, these investigations typically included less frequent sampling, limiting the precision of temporal characterization. By incorporating more frequent and extended intervals, our study provides improved temporal resolution and refines previously described laboratory trends before and after rewarming (3, 16, 17). In our study, hepatic enzymes demonstrated a distinct injury-recovery trajectory. Alanine aminotransferase (ALT) levels peaked early, most prominently at T2 (6–12 h after birth), and remained elevated over several days, while aspartate aminotransferase (AST) peaked at T2 and declined steadily between 48 and 96 h. Previous studies have reported elevations in ALT and AST within the first 24 h and a peak between 24 and 72 h in neonates with birth asphyxia who did not undergo therapeutic hypothermia (17, 18). Our findings differ in that we included three sampling points within the first 24 h, allowing for a more granular understanding of early hepatic enzyme dynamics. This detailed temporal profiling provides insights into the timing and evolution of liver injury in neonates with HIE receiving neuroprotective treatment. Metabolic indicators such as arterial pH, pCO2, base deficit, and lactate showed rapid improvement over time, with the most severe derangements observed at T1 and resolution generally occurring by T4. Coagulation markers revealed a pattern of early coagulopathy, with prolonged PTT and elevated PT-INR at baseline that improved over time, while fibrinogen levels rose steadily from T3 onward. Cardiac injury markers showed transient elevations: CK peaked at T2 and declined thereafter. Cortisol levels varied widely, with a general decline over time, and creatinine levels reflected improving renal function across later timepoints. Collectively, these patterns highlight a systemic response to hypoxic-ischemic injury and recovery and demonstrate the value of serial lab monitoring in assessing organ function trajectories in HIE and underscores the importance of early and serial monitoring of specific laboratory biomarkers in neonates with HIE undergoing therapeutic hypothermia. The observed temporal patterns may help clinicians anticipate evolving organ dysfunction, adjust supportive therapies proactively, and identify infants at higher risk for adverse outcomes. The typical postnatal increase in bilirubin observed in neonates not undergoing therapeutic hypothermia is primarily attributed to enhanced hemolysis of fetal erythrocytes, immature hepatic conjugation capacity due to reduced UDP-glucuronosyltransferase (UGT1A1) activity, and increased enterohepatic circulation (19). In contrast to the expected physiologic rise in bilirubin among term neonates during the first few days of life, our cohort demonstrated comparatively lower peak bilirubin levels during therapeutic hypothermia (20). One potential explanation for this finding is that neonates with moderate to severe HIE have been shown to exhibit reduced heme oxygenase activity, the rate-limiting enzyme in the production of bilirubin (20, 21). In our cohort, lower total bilirubin concentrations at 12, 24, 72, and 96 h were significantly associated with more severe brain injury, as quantified by the Weeke MRI scores. Although speculative, this inverse relationship raises the possibility that bilirubin's antioxidant properties may confer neuroprotection in the setting of HIE (22). Alternatively, lower bilirubin levels in infants with more severe hypoxic-ischemic injury may reflect increased oxidative stress related consumption of bilirubin, a hypothesis that remains speculative and warrants further investigation (23). When the cohort was stratified into three groups—definite sentinel event, probable sentinel event, and no sentinel event, distinct differences in laboratory trends over time were observed, particularly for pH, partial pressure of carbon dioxide (pCO2), partial thromboplastin time (PTT), D-dimer, and white blood cell (WBC) count. The no sentinel event group exhibited the lowest pH and highest pCO2 values, suggesting more profound metabolic and respiratory derangements. In contrast, the definite and probable sentinel event groups demonstrated higher pH values and comparatively lower pCO2 levels. Prior studies have recognized that sentinel events influence biochemical findings in HIE, but have not characterized longitudinal laboratory changes. This study adds to this work by showing that temporal laboratory patterns differ across sentinel event categories (1, 3, 24). These findings are noteworthy, as they may provide insights into the timing and nature of the hypoxic-ischemic insult. Additionally, our study's stratification approach offers insights into metabolic and coagulation profiles, contributing to the growing body of literature on the importance of contextualizing laboratory values within the clinical presentation of HIE (3, 4, 17, 25–27). However, validation in a larger, prospective cohort is necessary to confirm these associations and establish their clinical utility in injury timing. Our study also aimed to evaluate the association between routine bedside laboratory values and MRI-defined brain injury, exploring the potential of these systemic parameters to serve as early biomarkers of neurologic injury. Furthermore, aligning laboratory trajectories with MRI findings offers a framework to refine prognostic discussions with families and tailor follow-up strategies based on individual risk profiles. Our findings demonstrated that pCO2, lactate, ALT, AST, pH, PT-INR, PTT and D-dimer, were significantly associated with brain injury patterns as assessed using the Weeke scoring system (9). Consistent with our findings, several previous studies have demonstrated that lower pCO2 levels are associated with more severe MRI-defined brain injury in neonates with HIE (28–31). Elevated lactate concentrations were associated with short-term MRI-defined brain injury involving the gray matter, white matter, and cerebellum in our study. Prior research has shown that lactate levels are reliable predictors of long-term adverse neurological outcomes in neonates with HIE undergoing therapeutic hypothermia, as assessed at one to two years of age using the Bayley Scales of Infant and Toddler Development (32, 33). The observed abnormalities in coagulation markers in our study, including elevated D-dimer and prolonged PTT, align with findings from Sweetman et al., who reported that prolonged PT and PTT on days 1, 2, and 3 after birth in neonates undergoing TH correlated with MRI injury patterns and adverse outcomes in cooled neonates (34). Consistent with findings from the Sweetman study, we observed that a prolonged prothrombin time (PT) at 48 h and partial thromboplastin time (PTT) at 24 h were associated with MRI-defined brain injury. Additionally, prolonged PT and PTT at 96 h were significantly correlated with higher Weeke MRI scores, indicating more severe injury. In conclusion, our findings support the potential role of laboratory biomarkers as early indicators of neurological injury in neonates with HIE. These markers may ultimately facilitate more personalized therapeutic approaches and enhance risk stratification to improve clinical outcomes. In this study, we employed predictive modeling to integrate clinical laboratory values obtained during three early postnatal time intervals (0–6 h, 7–12 h, and 13–24 h) with the aim of enhancing prognostic accuracy for neonatal brain injury. Our analysis demonstrated that lactate, partial pressure of carbon dioxide (pCO2), and pH measured within the first 0–6 h of life had the highest predictive value for total brain injury, as quantified by the Weeke Score. This combined modeling approach provides a novel framework for the development of predictive calculators in future studies, enabling early identification of neonates at greatest risk for brain injury within the critical first hours of life and potentially informing timely, targeted clinical interventions. When performing variable selection, we did not impose heredity constraints on the inclusion of biomarkers from the first three timepoints or interactions (e.g., if a biomarker at a later timepoint is included, then this necessitates inclusion of this biomarker at earlier timepoints); however, such extensions are possible for quantifying biomarker value for early detection of the injury (35). Within the first 6–12 h of life, lactate, pH, pCO2, and base deficit demonstrated the strongest and most consistent associations with total MRI injury severity. Early integration of these routinely available laboratory values may support risk stratification during the initial postnatal period while clinical evolution is pending. Our study has several limitations that warrant consideration. First, the single-center design may limit the generalizability of our findings, as clinical practices, patient populations, and therapeutic hypothermia management protocols can vary across institutions. The degree to which such inter-institutional variability impacts laboratory trends or MRI outcomes in neonates with HIE remains uncertain. Second, the timing of laboratory sample collection was not uniform across subjects; instead, samples were grouped into predefined postnatal time intervals, with some time points containing missing values. This variability may have reduced the temporal resolution of analyses and introduced potential bias. Furthermore, it is important to consider that some laboratory derangements may reflect therapy-related effects rather than primary injury. For example, platelet dysfunction observed during hypothermia may be iatrogenic and reversible, rather than a direct consequence of the initial hypoxic insult (36). Because half of the study population was outborn, laboratory values were more frequently missing at the 0–6-hour timepoint, with fewer missing values at later timepoints. Although a protocol specified laboratory sampling timepoints, bedside clinicians could reduce the number of samples based on the neonate's clinical course, resulting in missing laboratory measurements at later timepoints. Due to the missing data, we statistically evaluated whether the pattern of missingness of the biomarkers selected as best predictors in the multivariable predictive models was informative, by comparing the distributions of the response (MRI) and the selected predictors in the “complete data” group and the “partially observed” group. Specifically, using the Kolmogorov–Smirnov test (p > 0.36) and the Kruskal–Wallis test (p > 0.11), we found no evidence of a “distribution shift” in the response (MRI); the results for selected predictors were similar. As the distributions of these variables did not differ statistically across the two groups, this investigation provides evidence against the hypothesis of informative data missingness (e.g., where missing predictors could be associated with more severe cases) and suggests that subjects with partially missing biomarkers were not clinically distinct from those with complete data. The fact that the “complete data” analyses had stronger association metrics (R2) than the “imputed data” analyses further reaffirms the conservatism of our analytic approach. However, this also suggests a limitation of our dataset that a very informative clinical predictor may not have been identified due to the missingness, either due to high proportion of missing values or due to the “signal attenuation” after the imputation. Not all MRIs were obtained within the 3–6-day window, which may have introduced variability in injury assessment. In addition, not all subjects experienced a clearly defined sentinel event, introducing uncertainty in the timing of injury onset that may have influenced measured laboratory concentrations. Because sentinel event classification was performed retrospectively and relied on available clinical documentation, some degree of misclassification is possible, particularly among outborn infants with incomplete perinatal records. Finally, the retrospective classification of sentinel events relied on clinical documentation, which is inherently subject to misclassification, particularly given that approximately 58% of the cohort was outborn, limiting access to complete perinatal records. This limitation may have affected the accuracy of group stratification and subsequent interpretation of laboratory trends by sentinel event status.
What the sources say
- Supportedcites [9] Weeke, 2018, A novel magnetic resonance imaging score predicts neurodevelopmental outcome after perinatal asphyxia and therapeutic hypothermia, J Pediatr source
The Methods passage describes the MRI brain-injury scoring system developed by Weeke and colleagues, including its anatomical subscores. The citation identifies the scoring system used; the reported associations with blood markers are explicitly the citing authors’ own findings, not findings attributed to Weeke. (LLM, conf=0.93)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Alanine transaminase (ALT, U/L) concentrations peaked at T2 (median 50), relative to the baseline at T1 (median 25) (p < 0.05)”
§ Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia > Results > CO2 Laboratory trends over time
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In parallel, serum creatinine (mg/dL) values steadily declined from T4 through T7(p < 0.05)”
§ Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia > Results > CO2 Laboratory trends over time
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
61 more claims
Create a free account to see all 110 claims and every source verdict.
- It may state two separate claims as one. 36
- Probably not a substantial claim. 11
Citations
Cites
Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy
Kurinczuk, J. J., White-Koning, M., & Badawi, N. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.05.010 · Cited by 1,334 · cited 1×
“The estimated incidence of HIE is approximately 1.5 per 1,000 live births (2).”
InfluentialHypoxic-Ischemic Encephalopathy: A Review for the Clinician
Douglas-Escobar, M., & Weiss, M. D. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.3269 · Cited by 778
Self-citationBilirubin-Induced Neurologic Damage — Mechanisms and Management Approaches
Watchko, J. F., & Tiribelli, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1308124 · Cited by 393
Weeke, L. C., Groenendaal, F., Mudigonda, K., Blennow, M., Lequin, M. H., Meiners, L. C., van Haastert, I. C., Benders, M. J., Hallberg, B., & de Vries, L. S. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.09.043 · Cited by 260
Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia
Salhab, W. A., Wyckoff, M. H., Laptook, A. R., & Perlman, J. M. (2004) · PEDIATRICS · doi:10.1542/peds.114.2.361 · Cited by 256
Jolani, S., Debray, T. P. A., Koffijberg, H., van Buuren, S., & Moons, K. G. M. (2015) · Statistics in Medicine · doi:10.1002/sim.6451 · Cited by 192
Postnatal Lactate as an Early Predictor of Short-Term Outcome after Intrapartum Asphyxia
Shah, S. S., Tracy, M. B., & Smyth, J. P. (2003) · Journal of Perinatology · doi:10.1038/sj.jp.7211023 · Cited by 141
Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
Douglas-Escobar, M., & Weiss, M. D. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00144 · Cited by 125 · cited 1×
“Additionally, our study’s stratification approach offers insights into metabolic and coagulation profiles, contributing to the growing body of literature on the importance of contextualizing laboratory values within the clinical presentation of HIE (3, 4, 17, 25–27).”
Self-citationBiomarkers of Brain Injury in the Premature Infant
Douglas‐Escobar, M., & Weiss, M. D. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2012.00185 · Cited by 106
Self-citationHypoxic-Ischemic encephalopathy and therapeutic hypothermia: the hemodynamic perspective
Giesinger, R. E., Bailey, L. J., Deshpande, P., & McNamara, P. J. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.009 · Cited by 92
Metadata
- Authors
- Elias, M., Bliznyuk, N., Yasova Barbeau, D., Sukumar, S., Carlos Roig, J., Rajderkar, D., Sura, L., Wynn, J. L., & Weiss, M. D.
- Affiliations
- University of Florida (US)
- Envision Physician Services
- Department of Pediatrics, University of Florida
- Corresponding author
- Weiss, Michael D.
- Venue
- Frontiers in pediatrics
- Publisher
- Frontiers Media SA
- Published
- 2026-03-12
- Volume
- 14
- Pages
- 1743749-1743749
- ISSN
- 2296-2360 (ISSN-L)
- PMC
- PMC13017858
- OpenAlex
- W7135020843
- Semantic Scholar
- 0067ba2af24517e0e969f6fd1f0af3c92efd75d7
- Cited by
- 0
- References
- 35
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pediatrics (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Florida Health
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Keywords
- hypoxic-ischemic encephalopathy, therapeutic hypothermia, neonates, laboratory biomarkers, metabolic disorders, base deficit, arterial pH, lactate, coagulation markers, hepatic biomarkers, sentinel events, machine learning prediction, prognostic factors, rewarming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia. https://app.cochat.ai/papers/10.3389/fped.2026.1743749
- The paper
- Elias, M., Bliznyuk, N., Yasova Barbeau, D., Sukumar, S., Carlos Roig, J., Rajderkar, D., Sura, L., Wynn, J. L., & Weiss, M. D. (2026). Lab values in neonates with hypoxic ischemic encephalopathy over time during and after therapeutic hypothermia. Frontiers in pediatrics. https://doi.org/10.3389/fped.2026.1743749
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.